Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2012
09/27/2012US20120245216 Compositions and methods for treatment of neuropathic pain
09/27/2012US20120245095 Biglycan and related therapeutics and methods of use
09/27/2012US20120245093 Neuronal Viability Factor and Use Thereof
09/27/2012US20120245090 Method for screening an agent being useful for the treatment of dry eye and / or corneal and conjunctival lesion and pharmaceutical composition obtained by the method
09/27/2012US20120245089 Use of the sparc microenvironment signature in the treatment of cancer
09/27/2012US20120245051 Objective, quantitative method to predict histological subtype in non-small cell lung cancer
09/27/2012US20120245045 Methods and kits to identify invasive glioblastoma
09/27/2012US20120245044 Methods of determining chemotherapy response in cancer
09/27/2012US20120244638 Method and system for binding behavior analysis
09/27/2012US20120244637 Method and system for interaction analysis
09/27/2012US20120244636 Incorporation of methyl lysine into polypeptides
09/27/2012US20120244634 Method for detection of basic peptide and reagent for detection of basic peptide
09/27/2012US20120244632 Sterol glucoside toxins
09/27/2012US20120244631 Apparatus and Method for Determining Microscale Interactions Based on Compressive Sensors such as Crystal Structures
09/27/2012US20120244629 Method for predicting high-grade vesicoureteral reflux in children with a first febrile urinary tract infection
09/27/2012US20120244624 Analyzing method and system for test strips
09/27/2012US20120244618 Methods and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same
09/27/2012US20120244610 Photo-damage apparatus for sorting particles
09/27/2012US20120244596 Anticalins
09/27/2012US20120244594 Immunoaffinity isolation of modified peptides from complex mixtures
09/27/2012US20120244563 Method of detecting pancreatic cancer
09/27/2012US20120244562 method for diagnosing primary biliary cirrhosis (pbc) using novel autoantigens
09/27/2012US20120244561 Biochemical serum marker
09/27/2012US20120244560 Monoclonal antibody against human hig-1 polypeptide
09/27/2012US20120244559 Nanobeads covered with plasminogen as a direct support for cyclic amplification of the prion protein PrPSC
09/27/2012US20120244558 Methods for diagnosing irritable bowel syndrome
09/27/2012US20120244557 Immunoassays using antibodies specific to carbamazepine
09/27/2012US20120244556 Markers for identifying tumor cells, methods and kit thereof
09/27/2012US20120244555 Method of diagnosing mild traumatic brain injury
09/27/2012US20120244554 Method for the direct measure of molecular interactions by detection of light reflected from multilayered functionalized dielectrics
09/27/2012US20120244553 Biomarker of allergic disease and use of the same
09/27/2012US20120244552 Modified Method of Agglutination to Detect Infections Caused by Microorganisms
09/27/2012US20120244550 Image-based quantitation of molecular translocation
09/27/2012US20120244548 Methods Of Determining Skeletal Maturity
09/27/2012US20120244546 Antibodies specific to carbamazepine
09/27/2012US20120244545 Method for screening active agents that stimulate the expression of cert to improve the skin's barrier function
09/27/2012US20120244544 Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium
09/27/2012US20120244543 Methods for in vitro differentiation of th-17+ cells
09/27/2012US20120244529 Multiplex analysis of cells, particles, and other analytes
09/27/2012US20120244526 Identification of tissue for debridement
09/27/2012US20120244521 Methods for identifying a virulent strain of a virus
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244170 Treating cancer by modulating mex-3
09/27/2012US20120244148 Anti-interferon-alpha antibodies
09/27/2012US20120244141 Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
09/27/2012US20120244140 Screening method for substance capable of promoting recovery of skin barrier function technical field
09/27/2012US20120244077 Methods and compositions for maintenance of a functional wound
09/27/2012US20120244076 csPCNA Isoform Antibodies And Uses Thereof
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/27/2012US20120244067 Methods for inducing reversible stasis
09/27/2012US20120244039 Oestrus detector
09/27/2012US20120244037 Sensing device and biosensor
09/27/2012US20120241620 Optical control device, control device, and optical scope
09/27/2012US20120241321 Polypeptide marker for diagnosing and assessing vascular diseases
09/27/2012US20120241318 System and methods for determining an analyte concentration incorporating a hematocrit correction
09/27/2012US20120240656 Sensor Calibration
09/27/2012DE102011085027A1 Faserstoffbahnqualitätsmessung Fibrous web quality measurement
09/27/2012DE102011016143A1 Diagnostische Differenzierung zwischen einem akuten Koronarsyndrom und einer stabilen Angina pectoris Diagnostic differentiation between acute coronary syndrome and stable angina pectoris
09/27/2012DE102011006080A1 Nozzle of flow cytometer for fractionation of spermatozoa of e.g. bull, has inner flow channel with outlet cross-section that is reduced more in its first dimension compared with first dimension of inlet cross-section of channel
09/27/2012DE102011001550A1 Device useful e.g. for promoting and blending reagents, comprises at least one reaction cell with at least a cavity exhibiting an aperture for carrying reagents, at least one reagent reservoir and at least one piston
09/27/2012DE102011001474A1 Laser-Mikrodissektionsverfahren und Laser-Mikrodissektionsvorrichtung Laser microdissection and laser Mikrodissektionsvorrichtung
09/27/2012CA2831223A1 Micro-devices for disease detection
09/27/2012CA2831151A1 Aromatic-cationic peptides and uses of same
09/27/2012CA2831136A1 Classification of kinase inhibitors using nonlinear optical techniques
09/27/2012CA2830943A1 Peptides capable of forming a covalent complex, and uses thereof
09/27/2012CA2830787A1 Dominant negative hsp110 mutant and its use in prognosing and treating cancers
09/27/2012CA2830772A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012CA2830628A1 Composition for treatment and diagnosis of pancreatic cancer
09/27/2012CA2830613A1 Assay for screening compounds that selectively decrease the number of cancer stem cells
09/27/2012CA2830602A1 Distinguishing benign and malignant indeterminate thyroid lesions
09/27/2012CA2830591A1 Systems for custom coloration
09/27/2012CA2830562A1 Mucin 5b as a pancreatic cyst fluid specific biomarker for accurate diagnosis of mucinous cysts and other markers useful for detection of pancreatic malignancy
09/27/2012CA2830533A1 Microfluidic devices and methods of manufacture and use
09/27/2012CA2830461A1 A method of analysing a blood sample of a subject for the presence of a disease marker
09/27/2012CA2830329A1 Line-1 hypomethylation as a biomarker for early-onset colorectal cancer
09/27/2012CA2830304A1 Long interspersed nuclear elements (line-1) and alu hypomethylation as biomarkers for colorectal cancer metastasis
09/27/2012CA2830296A1 Method of screening antiretroviral compounds and vaccine
09/27/2012CA2830291A1 Method for detecting and quantifying a target molecule in a sample
09/27/2012CA2830069A1 Therapeutic agent for emphysema and copd
09/27/2012CA2829820A1 A method and apparatus for washing rock samples
09/27/2012CA2820956A1 Methods and compositions comprising il-7 receptor ligands
09/26/2012EP2503341A2 Modulators of Neuronal Regeneration
09/26/2012EP2503340A1 Diagnostic marker for relapsing primary idiopathic focal segmental glomerulosclerosis
09/26/2012EP2503339A1 Improved prediction of cardiovascular and metabolic disease development
09/26/2012EP2503338A2 CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
09/26/2012EP2503337A1 Organic colored microparticles, diagnostic reagent kit containing the same, and in vitro diagnosis method
09/26/2012EP2503336A1 Nanobeads coated with plasminogen as direct support for cyclic amplification of prion protein PrPsc
09/26/2012EP2503335A2 Method and device for detecting analytes
09/26/2012EP2503334A2 Identification of regulatory t cells via the global gene regulator SatB1
09/26/2012EP2503333A1 Electrophoretic analysis method
09/26/2012EP2503332A2 Sugar chain-capturing substance and use thereof
09/26/2012EP2503331A2 Method and system for the real-time automatic analysis of the quality of samples of processed fish meat based on the external appearance thereof, said samples travelling on a conveyor belt such that surface defects can be detected and the fish meat can be sorted according to quality standards
09/26/2012EP2503330A2 Multicapillary device for sample preparation
09/26/2012EP2503329A1 Ion mobility spectrometer and method for improving the detection sensitivity thereof
09/26/2012EP2503322A1 Device for inspecting small pharmaceutical products
09/26/2012EP2503318A2 Density measuring system and density measuring method
09/26/2012EP2502999A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/26/2012EP2502984A1 Multicellular aggregates of lymphomatous cells and method for preparing thereof
09/26/2012EP2502930A2 Method and compositions for detecting botulinum neurotoxin
09/26/2012EP2502631A1 Immune suppressor and its use
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 3937